SCHEMBL16320370

SCHEMBL16320370

Cc1cc(Nc2cc(-c3cccs3)n[nH]2)nc(Nc2ccc(NC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)nc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 6/20 0.37
LMNA P02545 1/20 0.36
MAPK14 Q16539 1/20 0.35
RAF1 P04049 4/20 0.35
MAPK3 P27361 2/20 0.35
KDR P35968 5/20 0.35
EGFR P00533 3/20 0.35
FLT3 P36888 2/20 0.35
KIT P10721 1/20 0.34
CCNE2 O96020 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
BTK Q06187 1/20 0.34
CDK8 P49336 2/20 0.33
CTSC P53634 1/20 0.33
CCNC P24863 1/20 0.33
TEK Q02763 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ABL1 P00519 1/20 0.33
BCR P11274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16320357 0.92 BRAF (0.43) BRAFMAPK14RAF1KDRFLT3
SCHEMBL16319830 0.88 BRAF (0.41) BRAFLMNAMAPK14RAF1MAPK3
SCHEMBL16320294 0.87 LMNA (0.41) BRAFLMNAMAPK14RAF1MAPK3
SCHEMBL16320148 0.87 BRAF (0.41) BRAFLMNAMAPK14RAF1MAPK3
SCHEMBL16319556 0.87 LMNA (0.42) BRAFLMNAMAPK14RAF1MAPK3
SCHEMBL16319505 0.86 BRAF (0.39) BRAFLMNAMAPK14RAF1MAPK3
SCHEMBL16320251 0.86 LMNA (0.41) BRAFLMNAMAPK14RAF1MAPK3
SCHEMBL16319952 0.85 LMNA (0.40) BRAFLMNAMAPK14RAF1MAPK3
SCHEMBL16320371 0.85 BRAF (0.33) BRAFMAPK14RAF1KDRCCNE2
SCHEMBL16320175 0.85 LMNA (0.39) BRAFLMNAMAPK14RAF1MAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221798-B2 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof Zhejian Hisun Pharmaceutical Co., Ltd. (CN) 2015-12-29 US disclosed
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF MAP4K2, MAP4K1, MAP4K3 BRAF 84/4885LMNA 3831/4885MAPK14 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.